Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William L Isley

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Current Treatment Options in Cardiovascular Medicine|October 14, 2006
Low-density lipoprotein cholesterol lowering in the prevention of CHD: how low should we go?William L Isley
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 18, 2004
Insulin: thoroughly modern therapyWilliam L Isley
Drugs of Today (Barcelona, Spain : 1998)|May 14, 2003
Pitavastatin (NK-104), a new HMG-CoA reductase inhibitorWilliam L. Isley
Expert Opinion on Drug Safety|October 31, 2003
Hepatotoxicity of thiazolidinedionesWilliam L Isley
Diabetes Technology & Therapeutics|February 3, 2005
What did PROVE-IT prove?William L Isley,
ACP Journal Club|March 17, 2006
Pioglitazone did not reduce a composite endpoint of macrovascular complications and increased risk for heart failure in type 2 diabetes with macrovascular diseaseWilliam L Isley
ACP Journal Club|November 3, 2005
Review: alpha-glucosidase inhibitors improve glycemic control but have uncertain effects on patient-important outcomes in type 2 diabetesWilliam L Isley
Postgraduate Medicine|December 6, 2017
Thyroid dysfunction in the severely ill and elderlyWilliam L Isley
Annals of Internal Medicine|August 6, 2002
Growth hormone therapy for adults: not ready for prime time?William L Isley
Diabetes Technology & Therapeutics|May 3, 2003
Glitazones: good for glycemia. Good for the liver?William L Isley
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Current Treatment Options in Cardiovascular Medicine|October 14, 2006
Low-density lipoprotein cholesterol lowering in the prevention of CHD: how low should we go?William L Isley
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 18, 2004
Insulin: thoroughly modern therapyWilliam L Isley
Drugs of Today (Barcelona, Spain : 1998)|May 14, 2003
Pitavastatin (NK-104), a new HMG-CoA reductase inhibitorWilliam L. Isley
Expert Opinion on Drug Safety|October 31, 2003
Hepatotoxicity of thiazolidinedionesWilliam L Isley
Diabetes Technology & Therapeutics|February 3, 2005
What did PROVE-IT prove?William L Isley,
ACP Journal Club|March 17, 2006
Pioglitazone did not reduce a composite endpoint of macrovascular complications and increased risk for heart failure in type 2 diabetes with macrovascular diseaseWilliam L Isley
ACP Journal Club|November 3, 2005
Review: alpha-glucosidase inhibitors improve glycemic control but have uncertain effects on patient-important outcomes in type 2 diabetesWilliam L Isley
Postgraduate Medicine|December 6, 2017
Thyroid dysfunction in the severely ill and elderlyWilliam L Isley
Annals of Internal Medicine|August 6, 2002
Growth hormone therapy for adults: not ready for prime time?William L Isley
Diabetes Technology & Therapeutics|May 3, 2003
Glitazones: good for glycemia. Good for the liver?William L Isley
Pageof 4